Literature DB >> 12467950

Schizophrenia Quality of Life Scale: validation of the Japanese version.

Yasuhiro Kaneda1, Akira Imakura, Akira Fujii, Tetsuro Ohmori.   

Abstract

This study was performed to test the validity and value of the Schizophrenia Quality of Life Scale as an assessment tool in a Japanese-language version (JSQLS). The subjects for the present study were 55 inpatients with a diagnosis of schizophrenia as defined by DSM-IV. The JSQLS was administered together with two other self-report measures, the Medical Outcomes Study 36-item short-form health survey questionnaire (SF-36) and the WHO QOL-26, to assess validity. Psychotic symptoms and extrapyramidal symptoms were assessed using the BPRS and the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS), respectively. All the scales (psychosocial, motivation/energy and symptoms/side effects) showed good internal consistency reliability (Cronbach's alpha=0.93, 0.73 and 0.80, respectively). The correlations of items with their scale total revealed that almost all items were significantly correlated with their own scale score. There were associations with relevant SF-36, WHO QOL-26, and DIEPSS scores. From the results of the testing of the reliability and validity of the JSQLS, it is concluded that the JSQLS is a simple and reliable scale.

Entities:  

Mesh:

Year:  2002        PMID: 12467950     DOI: 10.1016/s0165-1781(02)00240-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

Review 1.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

2.  Meta-analysis of physical activity and effects of social function and quality of life on the physical activity in patients with schizophrenia.

Authors:  Kazutaka Ohi; Yuzuru Kataoka; Takamitsu Shimada; Aki Kuwata; Hiroaki Okubo; Kohei Kimura; Toshiki Yasuyama; Takashi Uehara; Yasuhiro Kawasaki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-22       Impact factor: 5.270

3.  Validation of the Chinese version of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) in Taiwanese patients with schizophrenia.

Authors:  Po-Ju Kuo; Mei-Jin Chen-Sea; Ru-Band Lu; Ming-Shun Chung; Chien-Cheng Kuo; Wei-Che Huang; Hui-Ing Ma
Journal:  Qual Life Res       Date:  2007-09-21       Impact factor: 4.147

4.  Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore.

Authors:  Nan Luo; Boon-Kheng Seng; Feng Xie; Shu-Chuen Li; Julian Thumboo
Journal:  Qual Life Res       Date:  2007-11-21       Impact factor: 4.147

5.  The Relationship of Motivation and Neurocognition with Functionality in Schizophrenia: A Meta-analytic Review.

Authors:  Antonia Najas-Garcia; Juana Gómez-Benito; Tania B Huedo-Medina
Journal:  Community Ment Health J       Date:  2018-03-31

6.  Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.

Authors:  Koichiro Fujimaki; Terumichi Takahashi; Shigeru Morinobu
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

7.  Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Diego Novick; Josep Maria Haro; Jaume Aguado; Zhanglin Cui
Journal:  Qual Life Res       Date:  2012-12-14       Impact factor: 4.147

8.  Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.

Authors:  Naoki Hashimoto; Atsuhito Toyomaki; Minoru Honda; Satoru Miyano; Nobuyuki Nitta; Hiroyuki Sawayama; Yasufumi Sugawara; Keiichi Uemura; Noriko Tsukamoto; Tsukasa Koyama; Ichiro Kusumi
Journal:  Ann Gen Psychiatry       Date:  2015-01-22       Impact factor: 3.455

9.  Profile of blonanserin for the treatment of schizophrenia.

Authors:  Tomomi Tenjin; Seiya Miyamoto; Yuriko Ninomiya; Rei Kitajima; Shin Ogino; Nobumi Miyake; Noboru Yamaguchi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-29       Impact factor: 2.570

10.  Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia.

Authors:  Teruhisa Uwatoko; Miho Yoshizumi; Jun Miyata; Shiho Ubukata; Hironobu Fujiwara; Ryosaku Kawada; Manabu Kubota; Akihiko Sasamoto; Genichi Sugihara; Toshihiko Aso; Shinichi Urayama; Hidenao Fukuyama; Toshiya Murai; Hidehiko Takahashi
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.